| Patents for C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368) |
|---|
| 05/09/2007 | EP1781672A1 Solvent free amorphous rapamycin |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214538 fluoro or chromoionophore based on the covalent linkage of a fluoro or chromophore to an aza-crown-3 calix[4]arene ionophore; facilitating the treatment of various diseases, such as manic-depressive illness |
| 05/02/2007 | EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 05/02/2007 | CN1313470C Method for preparing N-methyl benzothiazole lifumeisu |
| 04/12/2007 | WO2007039463A1 Nnrt inhibitors |
| 04/12/2007 | CA2623728A1 Nnrt inhibitors |
| 04/11/2007 | CN1944430A Anti-cancer active compound depside peptide as derivative of natural product |
| 04/05/2007 | US20070078128 5-[6-Chloro-2-fluoro-3-((R)-5-methyl-6-oxo-1,4,5,6-tetrahydro-[1,2,4]triazin-3-ylmethyl)-phenoxy]-isophthalonitrile; contacting a phenylacetic acid compound with an amino acid ester in presence of a coupling reagent to produce an intermediate, then with Lawesson's reagent, finally with hydrazine; AIDS |
| 03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 03/29/2007 | US20070072792 Macrocyclic lactams and pharmaceutical use thereof |
| 03/28/2007 | CN1935833A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 03/22/2007 | WO2007031213A1 Dioxazine- and oxadiazine-substituted arylamides |
| 03/21/2007 | CN1934117A Macrolides and methods for producing same |
| 03/20/2007 | US7192932 Use of immunomodulating agents |
| 03/20/2007 | US7192742 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages |
| 03/13/2007 | CA2264063C Cryptophycin compounds |
| 03/07/2007 | EP1760083A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them |
| 03/07/2007 | EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | EP1343561B1 Serine protease inhibitors |
| 02/28/2007 | EP1240154B1 Serine protease inhibitors |
| 02/28/2007 | CN1302038C Method for producing aliphatic polyisocyanates having an uretdione, isocyanurate and imionooxadiazind-ione structure |
| 02/07/2007 | CN1298722C Indole carbazole alkaloid and its preparing method and use |
| 02/06/2007 | US7173154 Transfection reagents |
| 02/01/2007 | WO2007012464A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 02/01/2007 | CA2615581A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 01/25/2007 | WO2006065277A3 Heterocyclic aspartyl protease inhibitors |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021406 New neurokinin antagonists for use as medicaments |
| 01/24/2007 | EP1744755A2 Compounds and compositions as cathepsin s inhibitors |
| 01/24/2007 | CN1902182A Macrocyclic lactams and pharmaceutical use thereof |
| 01/24/2007 | CN1900070A 13-aza-1,15-pentadecanolide its preparing method and use as germicide |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/17/2007 | EP1742707A2 Treatment of cns disorders using cns target modulators |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/10/2007 | EP1740558A1 Benzoxazocines and their therapeutic use as monoamine reuptake inhibitors |
| 01/10/2007 | CN1894206A N-substituted-N-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 01/09/2007 | US7160875 Malonamide derivatives |
| 01/09/2007 | US7160854 Binaphthyl peptidomimetics for treating vancomycin resistant Staphylococcus aureas infections |
| 01/04/2007 | WO2007000098A1 SUBSTITUTED p-TRIFLUOROMETHYL PHENYLETHERS, THE PREPARATIO AND THE USE THEREOF |
| 01/03/2007 | EP1613602B1 Alkylated iminodibenzyls as antioxidants |
| 01/03/2007 | EP0958292B1 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 01/03/2007 | CN1887847A Substituted p-trifluoromethyl phenyl ether compound and its prepn and application |
| 12/21/2006 | US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents |
| 12/20/2006 | CN1882530A Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 12/19/2006 | US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/14/2006 | US20060281725 Agents and crystals for improving excretory potency of urinary bladder |
| 12/06/2006 | CN1875005A Malonamide derivatives blocking the activtiy of gamma-secretase |
| 12/05/2006 | US7145039 Transfection reagents |
| 11/30/2006 | WO2006127364A1 Apoptosis promoters |
| 11/30/2006 | CA2609202A1 Apoptosis promoters |
| 11/29/2006 | EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 11/29/2006 | EP1117801B1 Polyketide synthase enzymes and recombinant dna constructs therefor, for the production of compounds related to fk-506 and fk-520 |
| 11/23/2006 | US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 11/16/2006 | US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 11/15/2006 | EP1721901A1 Abc transporter inhibitor |
| 11/15/2006 | EP1720886A1 Macrolides and methods for producing same |
| 11/15/2006 | EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors |
| 11/14/2006 | CA2267376C Process for producing depsipeptide derivatives and novel intermediates therefor |
| 11/09/2006 | US20060252930 Fki-1366 substances and process for producing the same |
| 11/08/2006 | EP1294691B1 Serine protease inhibitors |
| 11/02/2006 | WO2005041899A3 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
| 11/02/2006 | EP1715883A1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof |
| 11/01/2006 | CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/31/2006 | US7129346 Crown ether chelators, including fluorescent derivatives chelate metal cations; detection, discrimination and quantification of metal cations |
| 10/24/2006 | US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers |
| 10/24/2006 | CA2261848C Cell adhesion inhibitors |
| 10/19/2006 | WO2005103041A3 Treatment of cns disorders using cns target modulators |
| 10/18/2006 | EP1711470A1 Malonamide derivatives blocking the activtiy of gamma-secretase |
| 10/18/2006 | CN1280277C Diamide invertebrate pest control agents contg. non-aromatic heterocyclic ring |
| 10/17/2006 | US7122537 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; improved organ, cell or tissue culture; diseases such as neurodegenerative diseases |
| 10/11/2006 | CN1279032C Process for the preparation of [1,4,5]-oxadiazepine derivatives |
| 10/11/2006 | CN1278735C Crystallographic form of a cyclic depsipeptide having improved activity |
| 10/05/2006 | US20060223745 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 10/04/2006 | EP1706392A2 Pesticidal heterocyclic dihaloallyl compounds |
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 08/31/2006 | WO2006074940A3 Macrocyclic compounds and compositions useful as bace inhibitors |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/16/2006 | EP1689231A2 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives |
| 08/09/2006 | EP1688425A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 08/09/2006 | CN1814611A Ligand compound for image diagnosis and its preparing method and compound for image diagnosis and its intermediate preparation |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087598 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 08/03/2006 | WO2006061417A3 Macrocyclic quinazole derivatives and their use as mtki |
| 08/01/2006 | CA2188400C Preparation of arthropodicidal oxadiazines |
| 07/26/2006 | EP1682521A1 Macrocyclic lactams and pharmaceutical use thereof |
| 07/26/2006 | CN1809542A Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof. |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/20/2006 | WO2006074940A2 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/20/2006 | WO2006074501A1 Peptidic compounds |
| 07/20/2006 | CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 07/20/2006 | CA2590664A1 Macrocyclic compounds and compositions useful as bace inhibitors |
| 07/19/2006 | CN1803798A Method for producing fungicide compand |
| 07/18/2006 | US7078446 (Meth) acrylate-substituted iminooxidiazine dione derivatives |
| 07/12/2006 | CN1802356A Alkylated iminodibenzyls as antioxidants |
| 07/11/2006 | US7074941 prepared by oxidizing corresponding N-alkyl-aryl- or -heteroarylaldimines with an aromatic percarboxylic acid or its salt in the presence of water, a water-soluble base, and a water-miscible solvent, at temperatures below 30 degrees C; starting material for making drugs |
| 06/27/2006 | US7067516 Compounds used as antiinflammatory agents and enzyme inhibitors |
| 06/27/2006 | US7067507 Macrocycles useful in the treatment of Alzheimer's disease |